Table 2. The comparison of oxidative markers between groups (Tukey's Honestly Significant Difference).

Markers	Groups		Mean±SD	p*
TOS (mmol H2O2 Eq/L)	10-5 Cilostazol Group (n=10)	10-6 Cilostazol	2.21±0.003	0.001
		10-7 Cilostazol	1.91±0.003	0.001
		Control	3.97±0.16	0.001
	10-6 Cilostazol Group (n=10)	10-5 Cilostazol	2.88±0.003	0.001
		10-7 Cilostazol	1.91±0.003	0.001
		Control	3.97±0.16	0.001
	10-7 Cilostazol Group (n=10)	10-5 Cilostazol	2.88±0.003	0.001
		10-6 Cilostazol	2.21±0.003	0.001
		Control	3.97±0.16	0.001
TAC (mmolTroloxEq/L)	10-5 Cilostazol Group (n=10)	10-6 Cilostazol	1.61±0.003	0.145
		10-7 Cilostazol	0.93±0.003	0.001
		Control	0.86±0.17	0.001
	10-6 Cilostazol Group (n=10)	10-5 Cilostazol	1.69±0.05	0.145
		10-7 Cilostazol	0.93±0.003	0.001
		Control	0.86±0.17	0.001
	10-7 Cilostazol Group (n=10)	10-5 Cilostazol	1.69±0.05	0.001
		10-6 Cilostazol	1.61±0.003	0.001
		Control	0.86±0.17	0.364
OSI AU	10-5 Cilostazol Group (n=10)	10-6 Cilostazol	1.37±0.001	0.316
		10-7 Cilostazol	2.05±0.003	0.238
		Control	4.76±0.83	0.001
	10-6 Cilostazol Group (n=10)	10-5 Cilostazol	1.70±0.05	0.316
		10-7 Cilostazol	2.05±0.003	0.004
		Control	4.76±0.83	0.001
	10-7 Cilostazol Group (n=10)	10-5 Cilostazol	1.70±0.05	0.238
		10-6 Cilostazol	1.37±0.001	0.004
		Control	4.76±0.83	0.001
SD: Standard deviation; TOS: Total oxidative status; TAC: Total antioxidant capacity; OSI: Oxidative stress index; AU: Arbitrary unit; * p<0.05 indicates statistical significance.